P22736 (NR4A1_HUMAN) Homo sapiens (Human)
Nuclear receptor subfamily 4immunitygroup A member 1 UniProtKBInterProSTRINGInteractive Modelling
It is possible new templates exist for this target since these models were created.
Available Structures
18 Experimental Structures
Description | PDB ID | Oligo-state | Range | Ligands | ||
---|---|---|---|---|---|---|
Crystal Structure of Human Nur77 Ligand-binding Domain in Complex with Ethyl 2-[2,3,4 trimethoxy-6(… | homo-2-mer | 2×TMY; 4×GOL; 1×NA; | ||||
Assess | ||||||
Crystal Structure Analysis of the NUR77 Ligand Binding Domain, S441W mutant | homo-2-mer | 3×GOL; | ||||
Assess | ||||||
Crystal Structure of the Human Nur77 Ligand-binding Domain | homo-2-mer | 3×GOL; | ||||
Assess | ||||||
Crystal Structure of TR3 LBD in complex with para-positioned 3,4,5-trisubstituted benzene derivativ… | homo-2-mer | 1×XBF; | ||||
Assess | ||||||
Crystal Structure Analysis of the DNPA-bounded NUR77 Ligand binding Domain | homo-2-mer | 3×GOL; 1×ZHN; | ||||
Assess | ||||||
Crystal Structure Analysis of the Csn-B-bounded NUR77 Ligand binding Domain | homo-2-mer | 1×E4L; | ||||
Assess | ||||||
Crystal Structure Analysis of the NUR77 Ligand Binding Domain, L437W,D594E mutant | homo-2-mer | 3×GOL; | ||||
Assess | ||||||
Crystal Structure of Human Nur77 Ligand-binding Domain in Complex with THPN | homo-2-mer | 1×T94; 7×GOL; | ||||
Assess | ||||||
Structural basis of NR4A1 bound to the human pituitary proopiomelanocortin gene promoter | homo-2-mer | 4×ZN; | ||||
Assess | ||||||
Crystal Structure of TR3 LBD_L449W in complex with Molecule 2 | monomer | 1×GOL; | ||||
Assess | ||||||
Crystal Structure of TR3 LBD in complex with Molecule 3 | monomer | 1×GOL; | ||||
Assess | ||||||
Crystal Structure of TR3 LBD in complex with 1-(3,4,5-trihydroxyphenyl)decan-1-one | monomer | 1×GOL; | ||||
Assess | ||||||
Crystal Structure of TR3 LBD S553A Mutant | monomer | 1×GOL; | ||||
Assess | ||||||
Crystal Structure of TR3 LBD in complex with DPDO | monomer | 1×GOL; | ||||
Assess | ||||||
Crystal Structure of TR3 LBD L449W Mutant | monomer | 1×GOL; | ||||
Assess | ||||||
Crystal Structure of TR3 LBD in complex with Molecule 5 | monomer | 1×GOL; | ||||
Assess | ||||||
Crystal Structure of TR3 LBD in complex with Molecule 6 | monomer | 2×GOL; | ||||
Assess | ||||||
Human NR4A1 ligand-binding domain | monomer | |||||
Assess |
8 SWISS-MODEL models
Template | Oligo-state | QMEANDisCo | Range | Ligands | Trg-Tpl Seq id (%) | |
---|---|---|---|---|---|---|
7wnh.4.A | monomer | 0.73 | 1×ZN; | 72.92 | ||
Assess | ||||||
7wnh.2.A | monomer | 0.72 | 2×ZN; | 72.92 | ||
Assess | ||||||
5uan.1.A | monomer | 0.63 | 2×ZN; | 32.42 | ||
Assess | ||||||
4nqa.2.A | monomer | 0.61 | 2×ZN; | 32.42 | ||
Assess | ||||||
3dzy.1.A | monomer | 0.61 | 2×ZN; | 32.52 | ||
Assess | ||||||
3dzy.1.B | monomer | 0.60 | 1×ZN; | 28.10 | ||
Assess | ||||||
7prv.1.A | monomer | 0.59 | 2×ZN; | 26.13 | ||
Assess | ||||||
7prv.1.B | monomer | 0.58 | 2×ZN; | 26.13 | ||
Assess |
9 SWISS-MODEL models built on isoform sequence
Template | Isoform | Oligo-state | QMEANDisCo | Range | Ligands | Trg-Tpl Seq id (%) |
---|---|---|---|---|---|---|
Isoform 2 | 7wnh.4.A | monomer | 0.73 | 1×ZN; | 72.92 | |
Assess | ||||||
Isoform 2 | 7wnh.2.A | monomer | 0.72 | 2×ZN; | 72.92 | |
Assess | ||||||
Isoform 2 | 5uan.1.A | monomer | 0.63 | 2×ZN; | 32.42 | |
Assess | ||||||
Isoform 2 | 3dzy.1.A | monomer | 0.61 | 2×ZN; | 32.52 | |
Assess | ||||||
Isoform 2 | 4nqa.2.A | monomer | 0.61 | 2×ZN; | 32.42 | |
Assess | ||||||
Isoform 2 | 3dzy.1.B | monomer | 0.60 | 1×ZN; | 28.10 | |
Assess | ||||||
Isoform 2 | 7prw.1.A | monomer | 0.59 | 2×ZN; | 26.35 | |
Assess | ||||||
Isoform 2 | 7prv.1.B | monomer | 0.58 | 2×ZN; | 26.35 | |
Assess | ||||||
Isoform 2 | 7kw7.1.F | monomer | 0.57 | 26.57 | ||
Assess |